ICU Medical (ICUI) Competitors

$99.04
+0.75 (+0.76%)
(As of 05/2/2024 ET)

ICUI vs. ATRI, MMSI, HAE, TNDM, IART, NARI, PRCT, ATEC, LMAT, and AXNX

Should you be buying ICU Medical stock or one of its competitors? The main competitors of ICU Medical include Atrion (ATRI), Merit Medical Systems (MMSI), Haemonetics (HAE), Tandem Diabetes Care (TNDM), Integra LifeSciences (IART), Inari Medical (NARI), PROCEPT BioRobotics (PRCT), Alphatec (ATEC), LeMaitre Vascular (LMAT), and Axonics (AXNX). These companies are all part of the "surgical & medical instruments" industry.

ICU Medical vs.

Atrion (NASDAQ:ATRI) and ICU Medical (NASDAQ:ICUI) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation, community ranking and media sentiment.

Atrion has higher earnings, but lower revenue than ICU Medical. ICU Medical is trading at a lower price-to-earnings ratio than Atrion, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atrion$169.33M4.31$19.41M$11.0337.62
ICU Medical$2.26B1.07-$29.66M-$1.23-80.52

Atrion has a beta of 0.62, meaning that its stock price is 38% less volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500.

ICU Medical received 254 more outperform votes than Atrion when rated by MarketBeat users. Likewise, 64.48% of users gave ICU Medical an outperform vote while only 55.60% of users gave Atrion an outperform vote.

CompanyUnderperformOutperform
AtrionOutperform Votes
129
55.60%
Underperform Votes
103
44.40%
ICU MedicalOutperform Votes
383
64.48%
Underperform Votes
211
35.52%

ICU Medical has a consensus target price of $123.00, suggesting a potential upside of 24.19%. Given Atrion's higher possible upside, analysts clearly believe ICU Medical is more favorable than Atrion.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Atrion
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
ICU Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Atrion had 1 more articles in the media than ICU Medical. MarketBeat recorded 6 mentions for Atrion and 5 mentions for ICU Medical. Atrion's average media sentiment score of 0.51 beat ICU Medical's score of 0.44 indicating that ICU Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Atrion
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
ICU Medical
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

66.2% of Atrion shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 22.8% of Atrion shares are held by company insiders. Comparatively, 6.7% of ICU Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Atrion has a net margin of 11.46% compared to Atrion's net margin of -1.31%. ICU Medical's return on equity of 8.07% beat Atrion's return on equity.

Company Net Margins Return on Equity Return on Assets
Atrion11.46% 8.07% 7.37%
ICU Medical -1.31%6.35%3.03%

Summary

Atrion beats ICU Medical on 9 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICUI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICUI vs. The Competition

MetricICU MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$2.41B$3.87B$4.92B$7.54B
Dividend YieldN/A2.14%2.81%3.98%
P/E Ratio-80.5219.98259.8718.74
Price / Sales1.0742.832,436.9090.21
Price / Cash6.4043.4447.7735.59
Price / Book1.134.344.834.31
Net Income-$29.66M$4.22M$103.74M$214.33M
7 Day Performance4.43%2.34%2.95%1.48%
1 Month Performance-4.18%-4.56%-4.16%-3.38%
1 Year Performance-47.22%8.19%5.17%8.97%

ICU Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATRI
Atrion
1.648 of 5 stars
$423.29
+0.8%
N/A-32.4%$744.99M$169.33M38.38712Analyst Downgrade
MMSI
Merit Medical Systems
4.5882 of 5 stars
$74.10
-1.3%
$93.78
+26.6%
-5.8%$4.30B$1.26B45.746,950Earnings Report
Analyst Report
HAE
Haemonetics
3.8594 of 5 stars
$92.05
+0.6%
$104.67
+13.7%
+14.4%$4.68B$1.17B37.423,034Upcoming Earnings
Short Interest ↑
Analyst Revision
News Coverage
TNDM
Tandem Diabetes Care
3.8519 of 5 stars
$36.69
-1.0%
$40.82
+11.3%
-5.3%$2.37B$747.72M-10.672,400News Coverage
Positive News
IART
Integra LifeSciences
4.7262 of 5 stars
$29.17
-0.2%
$44.89
+53.9%
-45.0%$2.29B$1.54B35.143,946Upcoming Earnings
Analyst Downgrade
NARI
Inari Medical
3.4303 of 5 stars
$37.34
-1.6%
$73.71
+97.4%
-30.0%$2.16B$493.63M-1,244.671,300Analyst Report
PRCT
PROCEPT BioRobotics
0.6011 of 5 stars
$52.98
+1.8%
$46.00
-13.2%
+116.3%$2.72B$136.19M-23.65626Earnings Report
Analyst Report
News Coverage
Gap Up
ATEC
Alphatec
4.3812 of 5 stars
$12.62
+0.2%
$23.63
+87.2%
-8.6%$1.74B$482.26M-8.14839Upcoming Earnings
LMAT
LeMaitre Vascular
2.8403 of 5 stars
$64.80
-2.2%
$69.33
+7.0%
+22.0%$1.45B$193.48M48.36614News Coverage
AXNX
Axonics
2.5644 of 5 stars
$66.57
-0.5%
$70.73
+6.2%
+27.2%$3.40B$366.38M-512.04797Earnings Report

Related Companies and Tools

This page (NASDAQ:ICUI) was last updated on 5/3/2024 by MarketBeat.com Staff

From Our Partners